Cortexyme Inc跌2.91% 股价跌破100美元大关

自选股智能写手2021-08-27

北京时间2021年08月27日21时37分，Cortexyme Inc（CRTX.us）股票出现波动，股价快速下跌2.91%。截至发稿，该股报99.14美元/股，成交量9488股，换手率0.03%，振幅3.17%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.75百万美元，每股收益-0.74美元，毛利-87000.00美元，市盈率-34.29倍。机构评级方面，在所有7家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2162024699?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","is_english":false,"pubTime":"2021-08-27 21:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2162024699","market":"us","top_or_hot":-1,"title":"Cortexyme Inc跌2.91% 股价跌破100美元大关","media":"自选股智能写手","content":"<div>\n<p>北京时间2021年08月27日21时37分，Cortexyme Inc（CRTX.us）股票出现波动，股价快速下跌2.91%。截至发稿，该股报99.14美元/股，成交量9488股，换手率0.03%，振幅3.17%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.75百万美元，每股收益-0.74美元，毛利-87000.00美元，市盈率-34.29倍。机构评级方面，在所有7家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210827213707775600ec&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cortexyme Inc跌2.91% 股价跌破100美元大关</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCortexyme Inc跌2.91% 股价跌破100美元大关\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 21:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210827213707775600ec&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2021年08月27日21时37分，Cortexyme Inc（CRTX.us）股票出现波动，股价快速下跌2.91%。截至发稿，该股报99.14美元/股，成交量9488股，换手率0.03%，振幅3.17%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.75百万美元，每股收益-0.74美元，毛利-87000.00美元，市盈率-34.29倍。机构评级方面，在所有7家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210827213707775600ec&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABP","symbol_name":"Landos Biopharma, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210827213707775600ec&s=b","article_id":"2162024699","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210827213707775600ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2162024699","pubTimestamp":1630071426,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2021年08月27日21时37分，Cortexyme Inc股票出现波动，股价快速下跌2.91%。Cortexyme Inc股票所在的生物技术行业中，整体跌幅为0.95%。Cortexyme Inc公司简介：Cortexyme Inc是一家临床阶段的生物制药公司，致力于开发可改善疾病的治疗方法来治疗阿尔茨海默氏症和其他退行性疾病。消息层面，截至21时37分，Cortexyme Inc股票正面舆情新闻比例50%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LABP":"Landos Biopharma, Inc.","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc.","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics"},"translate_title":"Cortexyme Inc. fell 2.91 percent below the $100 mark","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"SANA":1,"CRTX":0.9},"content_text":"北京时间2021年08月27日21时37分，Cortexyme Inc（CRTX.us）股票出现波动，股价快速下跌2.91%。截至发稿，该股报99.14美元/股，成交量9488股，换手率0.03%，振幅3.17%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.75百万美元，每股收益-0.74美元，毛利-87000.00美元，市盈率-34.29倍。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，14%的券商给予持有建议，29%的券商给予卖出建议。Cortexyme Inc股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Renovorx, Inc.、Reneo Pharmaceuticals, Inc.、Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)涨幅较大，Renovorx, Inc.、Cassava Sciences Inc、Pharmacyte Biotech Inc较为活跃，换手率分别为28.42%、15.19%、6.51%，振幅较大的相关个股有Renovorx, Inc.、Cassava Sciences Inc、Avenue Therapeutics Inc，振幅分别为24.79%、11.57%、9.36%。Cortexyme Inc公司简介：Cortexyme Inc是一家临床阶段的生物制药公司，致力于开发可改善疾病的治疗方法来治疗阿尔茨海默氏症和其他退行性疾病。 它的方法是基于对牙龈卟啉单胞菌或牙龈卟啉单胞菌的存在的开创性发现，以及其分泌的毒性毒力因子蛋白酶称为gingipains。 该公司仅在开发和商业化治疗剂的一个可报告部门运营。消息层面，截至21时37分，Cortexyme Inc股票正面舆情新闻比例50%。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2162024699"}